article for covid-19
Answers
Explanation:
WHO is bringing the world’s scientists and global health professionals together to accelerate the research and development process, and develop new norms and standards to contain the spread of the coronavirus pandemic and help care for those affected.
The R&D Blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus.
The solidarity of all countries will be essential to ensure equitable access to COVID-19 health products.
Answer:
In early April, researchers measured seroprevalence of antibodies to SARS-CoV-2 among residents in Santa Clara Country. Using their data, the team calculated COVID-19 prevalence estimates 50–85-fold more than the number of confirmed cases. This implies that the infection is much more widespread than indicated by the number of confirmed cases.